140 related articles for article (PubMed ID: 36322715)
1. Fluctuations in Thyroid Hormone Levels During Initial Treatment for Differentiated Thyroid Carcinoma are Associated with Changes in Hemostasis: A Prospective Cohort Study.
Links MH; Lefrandt JD; Lisman T; van der Boom T; Lukens MV; Meijer K; Links TP; Zandee WT
Thyroid; 2023 Feb; 33(2):203-213. PubMed ID: 36322715
[No Abstract] [Full Text] [Related]
2. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.
Pellegriti G; Scollo C; Regalbuto C; Attard M; Marozzi P; Vermiglio F; Violi MA; Cianci M; Vigneri R; Pezzino V; Squatrito S
Clin Endocrinol (Oxf); 2003 May; 58(5):556-61. PubMed ID: 12699436
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia.
Verkleij CJ; Stuijver DJ; van Zaane B; Squizzato A; Brandjes DP; Büller HR; Meijers JC; Gerdes VE
Thromb Haemost; 2013 Feb; 109(2):214-20. PubMed ID: 23197299
[TBL] [Abstract][Full Text] [Related]
5. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction and hemostasis: an issue still unresolved.
Franchini M; Montagnana M; Manzato F; Vescovi PP
Semin Thromb Hemost; 2009 Apr; 35(3):288-94. PubMed ID: 19452404
[TBL] [Abstract][Full Text] [Related]
7. [Thyroid and hemostasis].
Franchini M
Recenti Prog Med; 2006 May; 97(5):267-71. PubMed ID: 16838559
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic changes in thyroid diseases: haemostasis and thrombosis.
Franchini M
Hematology; 2006 Jun; 11(3):203-8. PubMed ID: 17325963
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications.
Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A
Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680
[TBL] [Abstract][Full Text] [Related]
10. Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
Abdulrahman RM; Delgado V; Hoftijzer HC; Ng AC; Ewe SH; Marsan NA; Holman ER; Hovens GC; Corssmit EP; Romijn JA; Bax JJ; Smit JW
Thyroid; 2011 May; 21(5):471-6. PubMed ID: 21417919
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy.
Yango J; Alexopoulou O; Eeckhoudt S; Hermans C; Daumerie C
Eur J Endocrinol; 2011 Apr; 164(4):599-603. PubMed ID: 21257724
[TBL] [Abstract][Full Text] [Related]
12. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer.
McGriff NJ; Csako G; Gourgiotis L; Lori C G; Pucino F; Sarlis NJ
Ann Med; 2002; 34(7-8):554-64. PubMed ID: 12553495
[TBL] [Abstract][Full Text] [Related]
13. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.
Erem C; Ucuncu O; Yilmaz M; Kocak M; Nuhoglu I; Ersoz HO
Endocrine; 2009 Feb; 35(1):75-80. PubMed ID: 18958631
[TBL] [Abstract][Full Text] [Related]
14. Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
Gazdag A; Nagy EV; Erdei A; Bodor M; Berta E; Szabó Z; Jenei Z
J Endocrinol Invest; 2015 Feb; 38(2):133-42. PubMed ID: 25194423
[TBL] [Abstract][Full Text] [Related]
15. The influence of thyroid function on the coagulation system and its clinical consequences.
Elbers LPB; Fliers E; Cannegieter SC
J Thromb Haemost; 2018 Apr; 16(4):634-645. PubMed ID: 29573126
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012.
Carhill AA; Litofsky DR; Ross DS; Jonklaas J; Cooper DS; Brierley JD; Ladenson PW; Ain KB; Fein HG; Haugen BR; Magner J; Skarulis MC; Steward DL; Xing M; Maxon HR; Sherman SI
J Clin Endocrinol Metab; 2015 Sep; 100(9):3270-9. PubMed ID: 26171797
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma.
Luster M; Lassmann M; Haenscheid H; Michalowski U; Incerti C; Reiners C
J Clin Endocrinol Metab; 2000 Oct; 85(10):3640-5. PubMed ID: 11061516
[TBL] [Abstract][Full Text] [Related]
18. Hemostasis and thyroid diseases revisited.
Franchini M
J Endocrinol Invest; 2004 Oct; 27(9):886-92. PubMed ID: 15648557
[TBL] [Abstract][Full Text] [Related]
19. Prothrombotic changes due to an increase in thyroid hormone levels.
Horacek J; Maly J; Svilias I; Smolej L; Cepkova J; Vizda J; Sadilek P; Fatorova I; Zak P
Eur J Endocrinol; 2015 May; 172(5):537-42. PubMed ID: 25637077
[TBL] [Abstract][Full Text] [Related]
20. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
